What is the appropriate management for reduced fetal movements of twin B at 28 weeks gestation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Reduced Fetal Movements in Twin B at 28 Weeks

Immediately perform cardiotocography (CTG) and ultrasound assessment including umbilical artery Doppler on twin B to evaluate fetal well-being and exclude fetal growth restriction or placental insufficiency.

Initial Assessment Algorithm

When twin B shows reduced movements at 28 weeks, this represents a red flag requiring urgent evaluation, as reduced fetal movements are associated with increased risk of stillbirth, fetal growth restriction, and adverse perinatal outcomes 1.

Immediate Evaluation Steps:

1. Cardiotocography (Non-Stress Test)

  • Perform CTG immediately to assess fetal heart rate patterns and reactivity 1
  • A woman's subjective assessment of reduced movements should prompt assessment with CTG 1
  • This is the first-line test available in most settings 2, 3

2. Comprehensive Ultrasound Assessment

  • Biometry of twin B: Measure estimated fetal weight to determine if growth restriction is present
  • Amniotic fluid volume: Assess for oligohydramnios
  • Umbilical artery Doppler: Critical to evaluate placental function 4
  • Direct visualization of fetal movements: Confirm or refute maternal perception 3

3. Advanced Cardiac Assessment (if available)

  • Consider fetal tricuspid annular plane systolic excursion (f-TAPSE), as this independently predicts poor perinatal outcome in pregnancies with reduced movements 5
  • This may provide additional risk stratification beyond conventional testing

Risk Stratification and Management Based on Findings

If Fetal Growth Restriction is Identified:

Normal Umbilical Artery Doppler:

  • Weekly CTG monitoring 4
  • Serial growth assessments every 2-3 weeks
  • Plan delivery at 37 weeks if severe FGR (EFW <3rd percentile) 4
  • Plan delivery at 38-39 weeks if EFW between 3rd-10th percentile 4

Abnormal Umbilical Artery Doppler (decreased end-diastolic velocity):

  • Weekly umbilical artery Doppler evaluation 4
  • Weekly CTG monitoring, increasing frequency as needed 4
  • Plan delivery at 37 weeks 4

Absent End-Diastolic Velocity:

  • Doppler assessment 2-3 times per week 4
  • Increased CTG frequency 4
  • Plan delivery at 33-34 weeks 4
  • Administer antenatal corticosteroids immediately (at 28 weeks, this is indicated for anticipated preterm delivery) 4
  • Administer magnesium sulfate for neuroprotection (pregnancy <32 weeks) 4

Reversed End-Diastolic Velocity:

  • Hospitalize immediately 4
  • Administer antenatal corticosteroids 4
  • Administer magnesium sulfate for neuroprotection 4
  • CTG monitoring at least 1-2 times daily 4
  • Plan delivery at 30-32 weeks 4

If No Growth Restriction but Persistent Reduced Movements:

  • Repeat CTG and ultrasound assessment
  • Consider admission for continuous monitoring if movements remain absent or severely reduced 6
  • Women presenting on multiple occasions with reduced movements are at increased risk of poor outcomes including fetal death 2
  • Do not reassure and discharge if movements remain subjectively reduced to the mother, even with normal initial testing

Critical Pitfalls to Avoid

Do not rely on kick counting alone - While some protocols use formal movement counts, maternal subjective perception is as valid as any formal counting method 3. The key is that the mother perceives a change from her baseline.

Do not dismiss normal CTG as complete reassurance - In late-onset or growth-restricted fetuses, normal umbilical artery Doppler cannot exclude placental dysfunction 1. Multiple modalities of surveillance are needed.

Do not delay corticosteroids - At 28 weeks with concerning findings (especially abnormal Dopplers), immediate steroid administration is critical as delivery may be indicated within days to weeks 4.

Twin-specific consideration - Twin B is at higher risk for growth restriction and adverse outcomes due to placental sharing patterns in monochorionic twins or unequal placental territory in dichorionic twins. The threshold for intervention should be lower than in singletons.

Ongoing Surveillance

If initial evaluation is reassuring but movements remain subjectively reduced:

  • Schedule follow-up within 1-2 weeks maximum
  • Instruct patient to return immediately if movements decrease further or cease
  • Consider weekly CTG and biweekly growth assessments until delivery
  • Lower threshold for admission and delivery in twin pregnancies compared to singletons

The management hinges on excluding acute fetal compromise (via CTG) and chronic placental insufficiency (via Doppler and growth assessment), as these are the primary pathologies associated with reduced movements that lead to stillbirth and neonatal morbidity 4, 1.

References

Research

Management of decreased fetal movements.

Seminars in perinatology, 2008

Research

Foetal cardiac function in third trimester pregnancies with reduced fetal movements.

Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology, 2022

Research

Proposed management for reduced fetal movements: five years' experience in one medical center.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.